Markus Skog Olsson

Director/Miembro de la Junta en Balticgruppen Bio AB .

Health Technology

Perfil

Markus Skog Olsson is currently a Director at Balticgruppen Bio AB.
He was previously a Director at Betagenon Sweden AB.

Empresas	Cargo	Inicio
Balticgruppen Bio AB Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Balticgruppen Bio AB is a Swedish biopharmaceutical company that develops activated protein kinase. The company was founded by Olof Karlsson, Thomas Edlund, and Helena Edlund. Thomas Edlund has been the CEO since incorporation.	Director/Miembro de la Junta	-

Empresas	Cargo	Fin
Betagenon Sweden AB Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden.	Director/Miembro de la Junta	-

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas privadas	2
Betagenon Sweden AB Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden.	Health Technology
Balticgruppen Bio AB Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Balticgruppen Bio AB is a Swedish biopharmaceutical company that develops activated protein kinase. The company was founded by Olof Karlsson, Thomas Edlund, and Helena Edlund. Thomas Edlund has been the CEO since incorporation.	Health Technology